U.S. Ophthalmic Compounding Pharmacies Market, By Drug, By Formulation, By Therapeutic Application, By Pharmacy Type

Description

U.S. Ophthalmic Compounding Pharmacies Market is estimated to be valued at USD 4.3 Bn in 2026 and is expected to reach USD 6.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 6.6 Bn

When a commercially available medicine does not fit the unique needs of an individual patient (human or animal), the drug is compounded by a certified pharmacist. When a patient may be unable to tolerate a commercially available drug, or when the particular formulation required may be unavailable, or the patient may require a treatment that is currently in short supply or has been withdrawn, compounding is carried out. Compounding is defined by the United States Pharmacopeia Convention (USP) as the preparation, mixing, assembling, altering, packaging, and labelling of a drug, drug-delivery device, or device under a licensed practitioner's prescription, medication order, or initiative in the course of professional practice.

Market Dynamics

The increasing launches of drugs and adoption of inorganic strategies such as collaborations by the key players operating in the market are expected to drive the market growth during the forecast period. For instance, in November 2020, Fagron Sterile Services, a U.S. Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA)-registered 503B outsourcing provider of sterile medications, launched its new innovative silicone-free bevacizumab (AVASTIN) injection using Groninger automation technology in collaboration with West Pharmaceutical Services, Inc., a U.S.-based pharmaceutical company. This silicon-free AVASTIN injection has a long shelf life of 150 days and can be administered safely for ophthalmic applications without depositing any unsafe silicon oil droplets into the eye.

Key features of the study

This report provides an in-depth analysis of the U.S. ophthalmic compounding pharmacies market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.S. ophthalmic compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fagron Sterile Services US, New Drug Loft & VLS Pharmacy, Nora Apothecary, Lifecare Pharmacy, Avella Specialty Pharmacy, Triangle Compounding Pharmacy, O'Brien Pharmacy, Tache Pharmacy, Northmark Pharmacy, Edge Pharma, and ImprimisRx
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The U.S. ophthalmic compounding pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. ophthalmic compounding pharmacies market

Market Segmentation

By Drug
- Mitomycin
- Amphotericin
- Fluconazole
- Voriconazole
- Tropicamide
- Atropine Sulfate
- Albumin 5%
- Cyclosporine 0.5-2%
- Moxifloxacin
- Gentamicin
- Vancomycin
- Amikacin
- Tobramycin
- Tetracycline
- Metronidazole
- Acetylcysteine
- Bevacizumab
- Tacrolimus
- Retinoic Acid
- Carosine
- Latanoprost
- Dorzolamide
- Brimonidine
- Timolol
- Others
By Formulation
- Eye Drops
- Ointments
- Injections
- Others
By Therapeutic Application
- Dry Eyes
- Glaucoma
- Cataracts
- Conjunctivitis
- Age-related Macular Degeneration
- Uveitis (Eye Inflammation)
- Others
By Pharmacy Type
- 503A
- 503B
Key Players Insights
- Fagron Sterile Services US
- New Drug Loft & VLS Pharmacy
- Nora Apothecary
- Lifecare Pharmacy
- Avella Specialty Pharmacy
- Triangle Compounding Pharmacy
- O'Brien Pharmacy
- Tache Pharmacy
- Northmark Pharmacy
- Edge Pharma
- ImprimisRx.

Product Code: CMI4921

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Formulation
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Pharmacy Type
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Epidemiology
PEST Analysis
Mergers And Acquisition Scenario
Reimbursement Scenario
Regulatory Scenario
Outsourcing Facility Checklist
Distribution Channel
Compounding Drug Overview
List Of Registered Outsourcing Facilities
Pricing Analysis
Compounding Drugs Insights

4. U.S. Ophthalmic Compounding Pharmacies Market, By Drug, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Mitomycin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Amphotericin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Fluconazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Voriconazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tropicamide
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Atropine Sulfate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Albumin 5%
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cyclosporine 0.5-2%
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Moxifloxacin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gentamicin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Vancomycin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Amikacin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tobramycin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tetracycline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Metronidazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Acetylcysteine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Bevacizumab
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tacrolimus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retinoic Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Carosine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Latanoprost
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Dorzolamide
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Brimonidine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Timolol
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. U.S. Ophthalmic Compounding Pharmacies Market, By Formulation, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Eye Drops
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ointments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Injections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. U.S. Ophthalmic Compounding Pharmacies Market, By Therapeutic Application, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Dry Eyes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Glaucoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cataracts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Conjunctivitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Age-related Macular Degeneration
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Uveitis (Eye Inflammation)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. U.S. Ophthalmic Compounding Pharmacies Market, By Pharmacy Type, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
503A
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
503B
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Competitive Landscape

Fagron Sterile Services US
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
New Drug Loft & VLS Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nora Apothecary
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lifecare Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Avella Specialty Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Triangle Compounding Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
O'Brien Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Tache Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Northmark Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Edge Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ImprimisRx
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us